title: Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
authors.affiliation: Harvard Medical School, Brigham and Women's, Boston, Massachusetts, USA. jfoody@partners.org
authors.forename: JoAnne M
authors.initials: JM
authors.lastname: Foody
authors.forename: W Virgil
authors.initials: WV
authors.lastname: Brown
authors.forename: Franklin
authors.initials: F
authors.lastname: Zieve
authors.forename: Adeniyi J
authors.initials: AJ
authors.lastname: Adewale
authors.forename: Doreen
authors.initials: D
authors.lastname: Flaim
authors.forename: Robert S
authors.initials: RS
authors.lastname: Lowe
authors.forename: Charlotte
authors.initials: C
authors.lastname: Jones-Burton
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Tershakovec
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000069059:Atorvastatin; D001384:Azetidines / Q000008:administration & dosage / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D000069438:Ezetimibe; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008055:Lipids / Q000097:blood*; D016015:Logistic Models; D008297:Male; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use*; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D001384:Azetidines; D015415:Biomarkers; D006538:Heptanoic Acids; D008055:Lipids; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin; D000069438:Ezetimibe